ARTICLE | Top Story
Panel votes against Symlin
July 26, 2001 7:00 AM UTC
The Endocrinologic and Metabolic Drugs Advisory Committee today voted 8-1 and 6-3 against approval of Amylin's Symlin pramlintide to treat Type I and Type II diabetes, respectively. The panel did vote...